Dopamine supersensitivity in the hypothalamus?
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001833:Body Temperature Regulation / Q000187:drug effects*; D001971:Bromocriptine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004876:Ergot Alkaloids / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D009410:Nerve Degeneration / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D010891:Piribedil / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D009435:Synaptic Transmission / Q000187:drug effects
D000978:Antiparkinson Agents; D004876:Ergot Alkaloids; D006892:Hydroxydopamines; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D010868:Pimozide; D001971:Bromocriptine; D011433:Propranolol; D010891:Piribedil; D003000:Clonidine; D003913:Dextroamphetamine; D004298:Dopamine